Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Chiarolanza

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Reumatismo|July 11, 2006
[HAQ-DI Italian version in systemic sclerosis]G La Montagna, G Cuomo, I Chiarolanza, et al.
Scandinavian Journal of Rheumatology|February 10, 2006
Low-dose intravenous cyclophosphamide in systemic sclerosis: an open prospective efficacy study in patients with early diffuse diseaseG Valentini, C Paone, G La Montagna, et al.
Clinical and Experimental Rheumatology|September 25, 2007
Twelve-month azathioprine as maintenance therapy in early diffuse systemic sclerosis patients treated for 1-year with low dose cyclophosphamide pulse therapyC Paone, I Chiarolanza, G Cuomo, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Reumatismo|July 11, 2006
[HAQ-DI Italian version in systemic sclerosis]G La Montagna, G Cuomo, I Chiarolanza, et al.
Scandinavian Journal of Rheumatology|February 10, 2006
Low-dose intravenous cyclophosphamide in systemic sclerosis: an open prospective efficacy study in patients with early diffuse diseaseG Valentini, C Paone, G La Montagna, et al.
Clinical and Experimental Rheumatology|September 25, 2007
Twelve-month azathioprine as maintenance therapy in early diffuse systemic sclerosis patients treated for 1-year with low dose cyclophosphamide pulse therapyC Paone, I Chiarolanza, G Cuomo, et al.
Pageof 1